Kentaroh Miyoshi

Kentaroh Miyoshi

Auto-generated profile, based on publicly available information

Kentaroh Miyoshi

Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HYHaruchika Yamamoto
Haruchika Yamamoto
SSSeiichiro Sugimoto
Seiichiro Sugimoto
TKTakeshi Kurosaki
Takeshi Kurosaki
KMKentaroh Miyoshi
Kentaroh Miyoshi
SOShinji Otani
Shinji Otani
STShinichi Toyooka
Shinichi Toyooka
Because chronic lung allograft dysfunction (CLAD) develops predominantly on one side after bilateral living-donor lobar lung transplantation (LDLLT), lung perfusion scintigraphy (Q-scinti) was expected to show a perfusion shift to the contralateral unaffected lung with the development of CLAD. Our study examined the potential usefulness of Q-scinti in the diagnosis of CLAD after bilateral LDLLT. We conducted a single-center retrospective cohort study of 58 recipients of bilateral LDLLT. The unilateral shift values on Q-scinti were calculated and compared between the CLAD group (N = 27) and the non-CLAD group (N = 31) from 5 years before to 5 years after the diagnosis of CLAD. The unilateral shift values in Q-scinti were significantly higher in the CLAD group than in the non-CLAD group from 5 years before the diagnosis of CLAD to 5 years after the diagnosis (P < 0.05). The unilateral shift values in Q-scinti were significantly correlated with the percent baseline values of the forced expiratory volume in 1 s (P = 0.0037), the total lung capacity (P = 0.0028), and the forced vital capacity (P = 0.00024) at the diagnosis of CLAD. In patients developing unilateral CLAD after bilateral LDLLT, Q-scinti showed a unilateral perfusion shift to the contralateral unaffected lung. Thus, Q-scinti appears to have the potential to predict unilateral CLAD after bilateral LDLLT.

5 November 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
HCHaruki Choshi
Haruki Choshi
KMKentaroh Miyoshi
Kentaroh Miyoshi
MTMaki Tanioka
Maki Tanioka
HAHayato Arai
Hayato Arai
STShin Tanaka
Shin Tanaka
STShinichi Toyooka
Shinichi Toyooka

16 February 2016 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
SSSeiichiro Sugimoto
Seiichiro Sugimoto
KMKentaroh Miyoshi
Kentaroh Miyoshi
MYMasaomi Yamane
Masaomi Yamane
TOTakahiro Oto
Takahiro Oto
Diffuse panbronchiolitis is a rare complex genetic disease predominantly affecting East Asians, and is characterized by chronic inflammation of the respiratory bronchioles and sinobronchial infection. Although long-term macrolide therapy has been shown to significantly improve the survival in patients with diffuse panbronchiolitis, some patients continue to deteriorate, eventually requiring lung transplantation. However, lung transplantation for diffuse panbronchiolitis has rarely been reported and the outcome in these patients remains unknown. We describe our experience of lung transplantation for diffuse panbronchiolitis. A total of 5 patients received long-term macrolide therapy and had airway colonization by Pseudomonas aeruginosa preoperatively. Three patients had undergone sinus surgery for chronic rhinosinusitis before the transplantation. Bilateral cadaveric lung transplantation was performed in 4 patients, and living-donor lung transplantation in 1. After the lung transplantation, 1 patient developed an A3 acute rejection episode; however, none of the recipients developed severe pneumonia or any fatal infections. One recipient developed chronic lung allograft dysfunction 3 years after the transplantation; however, none developed recurrence of diffuse panbronchiolitis. All of the 5 patients were still surviving after a median follow-up period of 4.9 years (3.7–12.3 years). Lung transplantation is a viable option for the treatment of progressive diffuse panbronchiolitis resistant to long-term macrolide therapy.

17 December 2019 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
YKYusuke Konishi
Yusuke Konishi
KMKentaroh Miyoshi
Kentaroh Miyoshi
TKTakeshi Kurosaki
Takeshi Kurosaki
SOShinji Otani
Shinji Otani
SSSeiichiro Sugimoto
Seiichiro Sugimoto
STShinichi Toyooka
Shinichi Toyooka

30 December 2018 in Respiratory Investigation
Verified
Journal Article
Closed access
STShin Tanaka
Shin Tanaka
KMKentaroh Miyoshi
Kentaroh Miyoshi
HHHisao Higo
Hisao Higo
TKTakeshi Kurosaki
Takeshi Kurosaki
SOShinji Otani
Shinji Otani
TOTakahiro Oto
Takahiro Oto

17 February 2023 in Clinical Transplantation
Verified
Journal Article
Closed access
KFKento Fujii
Kento Fujii
STShin Tanaka
Shin Tanaka
MIMegumi Ishihara
Megumi Ishihara
KMKei Matsubara
Kei Matsubara
KHKohei Hashimoto
Kohei Hashimoto
STShinichi Toyooka
Shinichi Toyooka